Category 05 · Private access

Peptide Telehealth Affiliate Programs for Approved Publishers

Peptides are the fastest-moving category in telehealth, and the one where the rules changed most in 2026. MarketHealth works only with licensed telehealth programs where a clinician prescribes through a licensed pharmacy. Never "research use only" sellers.

Apply for peptide offers Where the rules stand

Last reviewed October 4, 2026

Private access · Approval required

Peptide status boardOct 2026

FDA-approved peptide medicinesPrescribed after clinician review

Accepted

Compounded, where legally permittedEligible substances, licensed 503A pharmacy

Accepted

Removed from Category 2, April 2026No longer flagged, but not cleared to compound

Not yet

Recommended by FDA panel, July 2026Nonbinding; rulemaking still required

Pending

"Research use only" sellersUnapproved drugs marketed for human use

Never

The opportunity

Interest in peptide therapy has grown fast, driven by longevity, recovery and wellness audiences and by the success of GLP-1 medications, which are themselves peptides. People are searching for what peptides are, whether they're legal, and how to get them safely from a real clinician.

That search intent is valuable, and it's also where the most dangerous corners of health marketing sit. Much of the peptide market online is "research use only" vials sold with a wink. Publishers who send traffic there put their audiences and their own reputations at risk. The opportunity for serious publishers is to be the trusted guide: explain the rules honestly and send readers only to licensed programs.

Who the patients are: adults interested in longevity, recovery, metabolic health and healthy aging, often already following health podcasts and creators. Many are confused about what's legal. Clear, sourced explanations earn their trust.

Where the rules stand (October 2026)

Peptide regulation moved twice this year, and it's still moving. Here's the short version, with sources.

Date	What happened	What it means
Jul 23–24, 2026	FDA's Pharmacy Compounding Advisory Committee voted, by narrow margins, to recommend adding BPC-157, KPV, TB-500, MOTS-c, Semax and Epitalon to the 503A bulks list. It voted against emideltide (DSIP).	Recommendations are nonbinding. FDA must still decide and complete notice-and-comment rulemaking. None of these is an FDA-approved drug.
Apr 15, 2026	FDA announced it was removing 12 peptides from Category 2, the list of substances flagged for significant safety risks.	Removal isn't permission. These peptides aren't in Category 1 and aren't cleared for compounding by that change alone.
Next	A second advisory committee meeting is planned before the end of February 2027.	Expect more changes. We update briefs as rules are finalized.
Ongoing	FDA warning letters have rejected "research use only" disclaimers when a seller's website shows the products are meant for people.	A disclaimer doesn't make an unapproved drug legal. We don't accept these sellers.

For the latest status of each item, see the telehealth regulation tracker.

Sources: Orrick on the April 2026 Category 2 change; FDA advisory committee meeting, July 23–24, 2026; AJMC on the panel votes; FDA warning letter on "research use only" peptides.

What MarketHealth accepts

Every peptide advertiser on MarketHealth is a licensed telehealth program. A clinician evaluates each patient and prescribes only if appropriate, and a licensed pharmacy dispenses. Within that, programs vary:

Program type	What the patient gets	Typical conversion event
FDA-approved peptide medicines	Clinician care and a prescription for an approved product, such as metabolic or hormone-related medicines	Completed intake or first paid month
Compounded peptides, where permitted	Clinician care plus a substance a licensed pharmacy may legally compound at the time of prescribing	First paid month or first fill
Longevity and metabolic memberships	Labs, clinician consults and a plan that may or may not include peptide therapy	Membership sign-up

We don't accept offers for substances that can't currently be legally compounded or prescribed, even if they're trending. If the rules change, the brief changes with them.

Best-fit traffic

Longevity and health podcasts: long-form, nuanced conversations suit this category. Sponsor reads need spoken disclosure and approved talking points.
SEO explainers: "are peptides legal," "what's the difference between approved and compounded," and program comparisons with disclosure.
Newsletters: opt-in longevity, metabolic health and wellness lists.
YouTube: explainer content with clinicians or well-informed hosts.

Paid search and paid social are approval-required, and most platforms restrict ads for prescription and unapproved drugs. Fitness and bodybuilding audiences need extra care: performance claims are prohibited.

Category rules

Do

Say a licensed clinician decides whether treatment is appropriate
Describe regulatory status accurately, with a date and a source
Use the advertiser's approved wording for every product
Send traffic only to approved landing pages
Disclose your affiliate relationship clearly

Don't

Link to, mention or compare with "research use only" sellers
Describe a panel vote or Category 2 removal as FDA approval
Claim healing, injury recovery, anti-aging, muscle or performance benefits
Share dosing, "stacks," protocols or reconstitution instructions
Call compounded peptides "FDA-approved"

More detail is in the peptides section of the compliance guide.

How to evaluate a peptide program before you promote it

In this category, the program you recommend is your reputation. Check:

Licensed clinicians: does a clinician licensed in the patient's state evaluate every patient, and can they say no?
Licensed pharmacy: which pharmacy dispenses, and is it licensed to compound what it's dispensing?
Legal status: can the program show that each substance it offers is approved or currently eligible for compounding?
No research-chemical supply: nothing sold as "research use only," and no vials or supplies shipped without a prescription.
Honest marketing: does the advertiser's own site avoid healing and anti-aging promises?
Pricing and cancellation: are costs and renewal terms clear?

MarketHealth checks these before an advertiser is listed. If a program can't pass them, it isn't on the platform.

Content that works and stays compliant

"Are peptides legal?" explainers: approved versus compounded versus research-use-only, updated as rules change.
The 2026 changes explained: what the April Category 2 change and the July panel votes did and didn't do.
How to find a legitimate peptide clinic: licensing, pharmacy and prescription questions to ask.
GLP-1s are peptides: a bridge from the most familiar peptide medicines to the wider category.
Program comparisons: clinician access, labs, pharmacy transparency and pricing, with disclosure.

Tip: in a category full of hype, being the publisher who explains the rules plainly is the advantage. Dated, sourced explainers keep earning links and trust as the rules change.

For advertisers: run a licensed peptide program and want vetted publishers? Tell us about your program and we'll reply within one business day. Share your program details.

FAQ

Peptide affiliate questions

What are peptide telehealth affiliate programs?

Partnerships where publishers earn a commission for referring patients to licensed telehealth programs where a clinician may prescribe peptide therapy dispensed by a licensed pharmacy. On MarketHealth these offers are private and available to approved publishers.

Is BPC-157 legal to compound now?

Not yet, as of October 2026. FDA removed it from Category 2 in April 2026, and an advisory committee recommended adding it to the 503A bulks list in July 2026, but FDA must still complete rulemaking. It isn't an FDA-approved drug. MarketHealth doesn't accept offers for it until it's legally compoundable.

Can I promote "research use only" peptides?

No. FDA has repeatedly found that "research use only" labels don't protect sellers whose marketing shows the products are for people. MarketHealth never accepts these sellers, and publishers in our program can't link to them.

Can I talk about peptides for recovery or anti-aging?

Not as product claims. You can explain what research is being done and what regulators have said, with sources, but don't promise healing, recovery, anti-aging or performance benefits.

How do peptide offers pay?

Usually CPA on the first paid month or a membership sign-up, with revenue share for programs with ongoing care. Terms are shared after approval.

Private access

Bring your audience. We'll bring the offers worth promoting.

Telehealth offers on MarketHealth are available by approval only. Applications are reviewed by a person, not a script.

Apply for Private Access I'm an advertiser

Private offers. Publisher approval first.

MarketHealth has programs in this category. Apply through our Telehealth Publishers page to discuss the campaigns suited to your audience.

Advertiser identities, payouts, creatives, tracking links and campaign-specific terms are shared privately after the relevant approval. This page is a publisher recruitment resource, not a consumer treatment or pharmacy order page.

Apply for Private Publisher Access Browse Telehealth Categories

Who this category fits

This category is relevant to publishers covering clinical programs, metabolic health and peptide regulation.

A useful editorial angle

Distinguish approved medicines, compounded preparations and laboratory research products.

What your private brief will confirm

Current substance/formulation status, licensed provider and pharmacy, eligibility and approved claims.

Your brief also identifies approved traffic sources, landing pages, required disclosures and the conversion event used for attribution.

Research-use-only sales are separate from telehealth. An application is not authorization to promote a particular substance.

From application to approved campaign

Review the publisher requirements and apply through the Telehealth Publishers page.
Discuss your audience, websites, channels and service areas with the MarketHealth team.
Receive the campaign-specific brief and approved tracking links after review.

Apply for Private Publisher Access Browse Telehealth Categories

Explore related private affiliate programs

Complete requested topic list · 31 entries

Peptide Affiliate Programs & Publisher Information

All 31 requested peptide and related telehealth names are listed below. Private program, publisher-review and investigational information pages have different scopes. A listing does not establish treatment availability, FDA approval or permission to promote.

01 · Private program page

Tirzepatide

Existing page retained; current program and preparation permissions remain subject to review.